We partnered with Cleveland Diagnostics to develop a 1:20-minute medical animation introducing IsoPSA, a next-generation blood test designed to improve prostate cancer risk assessment. Our challenge was to show how IsoPSA moves beyond traditional PSA testing in a way physicians and patients could immediately understand.
IsoPSA analyzes structural changes in PSA proteins to better identify the likelihood of prostate cancer. We translated that complex biology into a visual narrative that explains how the test works and how it better informs decisions around biopsy. Clear, stylized visuals and the use of color help reduce visual complexity and make the story easier to grasp.
In just eighty seconds, the animation guides viewers through the clinical challenge, the limitations of conventional PSA testing, and how IsoPSA enables more precise risk stratification. The program is built upon rigorous research and close collaboration with the IsoPSA team, ensuring the underlying biology and clinical implications are accurate.
The final piece gives the IsoPSA team a versatile communication tool for presentations, digital platforms, and patient education. It strengthens clinical conversations and leaves viewers with an understanding of how IsoPSA can lead to more informed prostate cancer care.
Related Animations
